Ayer v. Liberty Life Assur. Co. of Boston

382 F. Supp. 2d 162, 2005 U.S. Dist. LEXIS 15748, 2005 WL 1804428
CourtDistrict Court, D. Maine
DecidedAugust 1, 2005
DocketCIV. 04-213-B-W
StatusPublished
Cited by3 cases

This text of 382 F. Supp. 2d 162 (Ayer v. Liberty Life Assur. Co. of Boston) is published on Counsel Stack Legal Research, covering District Court, D. Maine primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ayer v. Liberty Life Assur. Co. of Boston, 382 F. Supp. 2d 162, 2005 U.S. Dist. LEXIS 15748, 2005 WL 1804428 (D. Me. 2005).

Opinion

ORDER ON MOTION FOR JUDGMENT ON STIPULATED RECORD

WOODCOCK, District Judge.

Afflicted with myasthenia gravis, Plaintiff Linda E. Ayer challenges Defendant Liberty Life Assurance Company of Boston’s (Liberty) denial of her claim for long-term disability benefits. Because Liberty’s denial was supported by substantial evidence, this Court GRANTS Defendant’s Motion for Judgment on Stipulated Record (Docket # 11).

I. FACTUAL BACKGROUND

A.The Plaintiffs Claim

This case arises out of Ms. Ayer’s claim for long-term disability benefits under an insurance policy Liberty issued to her employer FleetBoston Financial Corporation (Fleet). Ms. Ayer filed suit under 29 U.S.C. § 1132(a)(1)(B), 1 the civil enforcement section of the Employee Retirement Income Security Act of 1974 (ERISA), alleging wrongful denial of long-term disability benefits payable under Liberty’s policy. See Compl. (Docket # 1).

B. Submission on a Stipulated Record

The parties have submitted this case for judgment on a stipulated record. See Docket # 11, 15, 19. “[T]o stipulate a record for decision allows the judge to decide any significant issues of material fact that he discovers.” Boston Five Cents Savings Bank v. Sec’y of Dep’t of Hous. & Urban Dev., 768 F.2d 5, 11-12 (1st Cir.1985); see also Bhd. of Locomotive Eng’rs v. Springfield Terminal Ry., 210 F.3d 18, 31 (1st Cir.2000), cert. denied, 531 U.S. 1014, 121 S.Ct. 571, 148 L.Ed.2d 489 (2000).

C. Myasthenia Gravis

Ms. Ayer began working at Fleet in 1976 and was employed most recently as a branch operations supervisor. D56-57. 2 Her last day of work was October 28, 2002, after her neurologist, Stephanie Lash, M.D., advised her to stay out of work because of speech problems caused by myasthenia gravis (MG). D56; D158. MG is an acquired autoimmune disorder of neuromuscular transmission. D747. “The distinctive feature of MG is fluctuating weakness of muscles, made worse by use of those muscles and improved at least partially by rest of the same muscles.” D752. MG affects people differently. Id. MG may affect the muscles which move the eyeball and hold the eyelids open, the muscles that control facial expressions, smiling, chewing, talking, or swallowing, and the muscles of the neck and limbs. Id. Weakness of the bulbar muscles (muscles which control chewing, swallowing, and articulation) can result in difficulty *165 swallowing and slurred speech. D748; D753; D760. MG can cause fatigue in leg and arm muscles, and patients can experience difficulty with activities such as combing hair, lifting objects repeatedly, climbing stairs, walking, and running. D748. MG symptoms may fluctuate from hour to hour, day to day, or over longer periods of time. D747. Symptoms are provoked or worsened by exertion, exposure to temperature extremes, infections, menses, excitement, and emotional stress. D748; D754.

D. September 1997 — October 8, 2002: Symptoms and Course of Treatment

In September 1997, Ms. Ayer noticed her right eyelid was drooping. D351. By December 1997, she began to experience difficulty talking and eating, and on these occasions, her tongue felt “thick,” as though it was stuck on the roof of her mouth. D351-353. She described her speech as “slurry” and “garbled”; she reported difficulty in forming sounds, “almost like [a] baby” and as if she had “marbles in [her] mouth”; and, she mentioned that solid foods felt like they got stuck upon swallowing. Id.; D355. She continued to report these symptoms to her primary care physician, Dr. Kenneth Simone, beginning December 1997, and on February 11, 1998, he referred her to Dr. Lash. D351-357.

When Ms. Ayer first saw Dr. Lash on April 3, 1998, she was no longer having any symptoms. D611. However, when she described her prior symptoms of eyelid drooping, thick tongue, and progressive difficulty speaking or swallowing, Dr. Lash recognized these symptoms as suggestive of “mild myasthenic process” and ordered a blood test to look for an elevated acetyl-choline receptor antibody level. 3 D611-612. The acetylcholine receptor antibody test results confirmed Ms. Ayer’s level was elevated at 3.1. D490. At her next visit, on April 23, 1998, Ms. Ayer reported no new symptoms, and Dr. Lash diagnosed her with “mild [MG] which at the present does not require medication intervention.” D610.

On July 8, 1998, Dr. Lash observed that, although Ms. Ayer complained of twitching around the eyes, bridge of nose, and arms over the past year, “no perceptible abnormal muscle contractions were appreciated around the eyes, nose or in the upper extremities” and specifically, “no fascicula-tions 4 were appreciated.” D609. Dr. Lash commented that muscle twitching is an unusual symptom for MG, one she was “not aware of in association with [MG].” Id. Dr. Lash determined medication was not necessary, but stated that if symptoms became more bothersome as the day wore on, Mestinon 5 may be considered. Id. After this visit, Ms. Ayer began taking Mes-tinon. D608.

At her August 24, 1998 office visit with Dr. Lash, Ms. Ayer reported that, after *166 taking Mestinon, she had blurred vision for thirty minutes, but she was able to continue working; she also experienced increasing headaches similar to the tension headaches she had experienced in the past. Id. Dr. Lash observed “there are apparent twitches of the orbicular oculi muscle,” but “no evidence of fatigue, no ptosis and ex-traocular motions are full without nystag-mus.” Id. Dr. Lash determined that Ms. Ayer’s symptoms had failed to respond to Mestinon . and recommended she gradually taper off the medication. Id.

In the fall of 1998, Ms. Ayer was seen at the Myasthenia Gravis Center at Brigham and Women’s Hospital for further testing. D585. The results of the Brigham and Women’s Electromyography and Nerve Conduction studies, including repetitive nerve stimulation testing, 6 suggested a “post-synaptic neuromuscular junction disorder.” D587. There was no evidence of a sensorimotor polyneuropathy, and all muscles examined in the left upper and lower extremities were normal. Id.

In January 1999, Ms. Ayer reported to Dr. Lash that she was “doing quite a bit better,” experiencing only occasional twitching. D607. Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hankins v. Standard Insurance
828 F. Supp. 2d 991 (E.D. Arkansas, 2011)
McIntyre v. Aetna Life Insurance
581 F. Supp. 2d 749 (W.D. Virginia, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
382 F. Supp. 2d 162, 2005 U.S. Dist. LEXIS 15748, 2005 WL 1804428, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ayer-v-liberty-life-assur-co-of-boston-med-2005.